- Webinar Speakers
Rami Mehio
Vice President of Instrument Software and Bioinformatics,
Product Development, Illumina Inc.Rami Mehio is Vice President, BioInformatics and Instrument Software at Illumina, Inc. (NASDAQ: ILMN). Formally VP of Engineering at Edico Genome, the creator of the DRAGEN BioIT processor, Rami now leads the BioInformatics development effort at Illumina, spanning methods development for primary and secondary analysis, software development, FPGA acceleration and embedding DRAGEN onto Illumina sequencers and the cloud. Rami also drives the development of the software that powers Illumina’s market-leading sequencers. With a strong track record of managing multi-disciplinary development teams and taking products to market, Rami has more than 20 years of technical management experience in various fields, including bioinformatics, FPGA development, cellular modem, RF IC, embedded software development and underwater acoustic modems.
- Webinar Abstract
Join us for a deep dive into how illumina’s DRAGEN BioIT platform supports researchers studying SARS-CoV-2 and metagenomics analysis in general. This analysis pipeline is currently free of use by Oct 2020 as a part of Illumina’s COIVD19 support initiative.
In this webinar we will provide an overview on Illumina’s products designed to address COVID19 sequencing requirements, including metagenomics shotgun sequencing, enrichment and amplicon panels. Then we will delve into the details on the SARS-CoV-2 NGS Data Toolkit, including DRAGEN and how this toolkit supports Covid-19 detection, screening and surveillance. We will showcase use of DRAGEN for metagenomics analysis pipeline as a microbiology research tool before finally sharing the latest COVID-Seq announcement from Illumina.